However, many types of cancer develop TRAIL resistance, which is related to the high expression levels of decoy receptors and antiapoptotic proteins, mutations in TRAIL receptors, and dysregulation of death-inducing signaling complex (DISC) formation [6,7,8]. This evidence concerns the gene TNFSF10 and cancer.